ATOX1 and breast neoplasm: Evaluation of the different PAM50 molecular subtypes using the METABRIC breast cancer data set shows significant correlations between high ATOX1 expression and decreased DSS for Luminal A, Luminal B and Normal-like breast tumors, but not for Claudin low, Basal-like and HER2-enriched tumors.